If this is the first time you are viewing this file, please choose 'Save As' from the 'File' menu and resave this file as an Excel file type. This will greatly speed up future viewings of this file.

Short-Term Individual Animal Non Neoplastic Diagnosis

Study Information:

Chemical Name: Dicyclohexylcarbodiimide
CASRN: ="538-75-0"
Study Number: C93021
Exposure Route: SKIN APPLICATION
TDMS Number: 9302101
Sex: Male
Strain and Species: F 344/N Rats

Male Individual Animal Non Neoplastic Diagnoses
System Organ Site Treatment Group Number Examined Cage Number Animal Number Days on Study Lesion Found Lesion Name Lesion Qualifier Removal Reason
Integumentary System Skin Control 17 MG/ML 5 17 17 10 1 Inflammation Mild, Focal, Chronic Active Moribund Sacrifice
Integumentary System Skin Control 17 MG/ML 5 20 20 11 1 Inflammation Minimal, Focal, Chronic Active Moribund Sacrifice
Integumentary System Skin Control, Epidermis 17 MG/ML 5 20 20 11 1 Necrosis Minimal, Focal Moribund Sacrifice
Integumentary System Skin Dermis, SOA 17 MG/ML 5 19 19 17 1 Edema Moderate, Focal Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 2 MG/ML 5 6 6 17 1 Hyperplasia Minimal, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 2 MG/ML 5 7 7 17 1 Hyperplasia Minimal, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 2 MG/ML 5 9 9 17 1 Hyperplasia Minimal, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 6 MG/ML 5 11 11 17 1 Hyperplasia Minimal, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 6 MG/ML 5 12 12 17 1 Hyperplasia Moderate, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 6 MG/ML 5 13 13 17 1 Hyperplasia Mild, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 6 MG/ML 5 14 14 17 1 Hyperplasia Moderate, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 16 16 11 1 Hyperplasia Moderate, Diffuse Moribund Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 19 19 17 1 Hyperplasia Moderate, Diffuse Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 6 MG/ML 5 12 12 17 1 Necrosis Mild, Focal Terminal Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 16 16 11 1 Necrosis Moderate, Focal Moribund Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 17 17 10 1 Necrosis Moderate, Focal Moribund Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 18 18 11 1 Necrosis Marked, Diffuse Moribund Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 20 20 11 1 Necrosis Marked Moribund Sacrifice
Integumentary System Skin Epidermis, SOA 17 MG/ML 5 19 19 17 1 Necrosis Mild, Focal Terminal Sacrifice
Integumentary System Skin SOA 6 MG/ML 5 12 12 17 1 Inflammation Mild, Focal, Chronic Active Terminal Sacrifice
Integumentary System Skin SOA 6 MG/ML 5 14 14 17 1 Inflammation Minimal, Focal, Chronic Active Terminal Sacrifice
Integumentary System Skin SOA 17 MG/ML 5 16 16 11 1 Inflammation Mild, Focal, Chronic Active Moribund Sacrifice
Integumentary System Skin SOA 17 MG/ML 5 17 17 10 1 Inflammation Moderate, Diffuse, Chronic Active Moribund Sacrifice
Integumentary System Skin SOA 17 MG/ML 5 19 19 17 1 Inflammation Moderate, Diffuse, Chronic Active Terminal Sacrifice